Profound Medical Corp PROF

Primary Symbol: T.PRN

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > Good week so far, hopefully earnings will help

<< Previous

Bullboard Posts

Next >>

Comment by HomerAndCompanyon Nov 23, 2024 3:40pm

28 Views

Post# 36327556

RE:RE:RE:Good week so far, hopefully earnings will help

Another way to look at the number of sites is that if the existing sites were just moderately busy, like an average of 1 treatment per week per site, Profound would be very near to the break even point. If the existing sites were anything remotely like "too busy" Profound would be making a very healthy profit. So if not hitting their target of 75 sites in 2024 becomes a "problem" it would be a very very good problem to have.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?